| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.094 | 0.005 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.089 | 0.006 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.09 | 0.006 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.007 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.12 | 0.008 |